Thomas A. West is CEO & President at Intersect ENT, Inc. (XENT). They have made 1 open-market trade across 1 company since 2020, most recently 2026-07-28.
CIK 0001620705
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $323K since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XENT | BUY | 2020-03-17 | 2020-03-18 | $8.48 | $323K | +27.6% | +10.6% | +34.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.